Showing 381 - 400 results of 743 for search '"transplant rejection"', query time: 0.32s Refine Results
  1. 381

    C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates by Robin Schmitz, Zachary W. Fitch, Paul M. Schroder, Ashley Y. Choi, Miriam Manook, Janghoon Yoon, Mingqing Song, John S. Yi, Sanjay Khandelwal, Gowthami M. Arepally, Alton B. Farris, Edimara S. Reis, John D. Lambris, Jean Kwun, Stuart J. Knechtle

    Published 2021-09-01
    “…Donor-specific antibodies in sensitized recipients may cause kidney transplant rejection. Here the authors show that complement component C3 inhibition prolongs graft survival by inhibiting T and B cell proliferation/activation and hence tissue injury, despite antibody levels remaining unaffected.…”
    Get full text
    Article
  2. 382

    Differentiation of adult human mesenchymal stem cells into dopaminergic neurons by Marjan Khademizadeh, Manoochehr Messripour, Nazem Ghasemi, Fariborz Momen beik, Ahmad Movahedian Attar

    Published 2019-01-01
    “…It is concluded that hADSCs can be easily taken from the patient’s own body and differentiated into dopaminergic cells having a lower risk of transplant rejection.…”
    Get full text
    Article
  3. 383

    The Reasons for Refusing Kidney Transplantation Among Iranian Patients Undergoing Peritoneal Dialysis by Fateme Biabani, Gholamhossein Mahmudirad, Hadi Hassankhani, Azad Rahmani

    Published 2022-08-01
    “…According to patients, kidney transplantation is a long-term procedure that causes financial stress and physical and social problems and there is a risk of transplant rejection. On the other hand, patients were accustomed to performing PD and considered it a part of their life. …”
    Get full text
    Article
  4. 384

    Ocular surface complications following biological therapy for cancer by Kevin Sheng-Kai Ma, Kevin Sheng-Kai Ma, Kevin Sheng-Kai Ma, Ping-Feng Tsai, Tina Yi-Jin Hsieh, Tina Yi-Jin Hsieh, James Chodosh

    Published 2023-06-01
    “…Dry eye, Stevens-Johnson syndrome, and corneal transplant rejection have all been reported following the use of immune checkpoint inhibitors. …”
    Get full text
    Article
  5. 385

    Role of dendritic cells in the induction of lymphocyte tolerance by Fabiola eOsorio, Camila eFuentes, Mercedes N Lopez, Flavio eSalazar-Onfray, Fermín eGonzález

    Published 2015-10-01
    “…Importantly, these findings are now being applied to human research in the contexts of autoimmune diseases, allergies, and transplant rejection. Indeed, DC-based immunotherapy research has made important progress in the area of human health, particularly in regards to cancer. …”
    Get full text
    Article
  6. 386

    SODIUM REABSORPTION ESTIMATION FOR EVALUATION OF FUNCTIONAL STATE OF TRANSPLANTED KIDNEY by I. E. Borodoulin, I. A. Pronchenko, I. P. Ermakova

    Published 2009-06-01
    “…In the group of recipients with chronic transplant rejection a free member of regression equation was significantly higher, than in health volunteers (р < 0,01). …”
    Get full text
    Article
  7. 387

    The challenges of managing psychiatric disorders in children with kidney transplant and end-stage renal disease: A case report by O. Fodor, A.-M. Ciubotariu, I. Mihailescu

    Published 2021-04-01
    “…Moreover, his medical history includes CRS (congenital renal disease), kidney transplant at the age of 2 followed with transplant rejection in 2019. Currently he is under haemodialysis and multiple drug prescriptions associated with his severe medical condition which interferes with the psychotropic treatment. …”
    Get full text
    Article
  8. 388

    Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies by Michael Eikmans, Els M. Gielis, Kristien J. Ledeganck, Jianxin Yang, Daniel Abramowicz, Frans F. J. Claas

    Published 2019-01-01
    “…Here, we provide an overview of the current status on research of biomarkers of acute kidney transplant rejection in blood and urine. We specifically discuss relatively novel research strategies in biomarker research, including transcriptomics and proteomics, and elaborate on donor-derived cell-free DNA as a potential biomarker.…”
    Get full text
    Article
  9. 389

    Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. by Cursiefen, C, Schlötzer-Schrehardt, U, Küchle, M, Sorokin, L, Breiteneder-Geleff, S, Alitalo, K, Jackson, D

    Published 2002
    “…METHODS: Human corneas exhibiting neovascularization secondary to keratitis, transplant rejection, trauma, and limbal insufficiency (n = 21) were assessed for lymphatic vessel content by conventional transmission electron microscopy and by immunostaining and immunoelectron microscopy with antibodies specific for the lymphatic endothelial markers, lymphatic vessel endothelial hyaluronan receptor (LYVE-1) and the 38-kDa integral membrane glycoprotein podoplanin. …”
    Journal article
  10. 390

    Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection. by Oliveira, V, Sawitzki, B, Chapman, S, Appelt, C, Gebuhr, I, Wieckiewicz, J, Long, E, Wood, K

    Published 2008
    “…Regulatory T cells (Treg) have been shown to play a role in the prevention of autoimmune diseases and transplant rejection. Based on an established protocol known to generate alloantigen reactive Treg in vivo, we have developed a strategy for the in vitro selection of Treg. …”
    Journal article
  11. 391

    Characterising the immune response to combined skin and solid organ transplants by Stark, H

    Published 2022
    “…Finally in Chapter 6 a human transgenic mouse model is used to explore the role of Langerhans cell related pathways in skin transplant rejection.</p> <p>This is the first study to characterise both the systemic and local immune response in a combined skin and solid organ transplant, offering unique insights into the dynamic changes in immune phenotype post-transplantation and during rejection. …”
    Thesis
  12. 392

    Does Lymphovenous Anastomosis Effect Mammalian Target of Rapamycin Inhibitor-associated Lymphedema Patients? by Inah Yoon, Hyung Bae Kim, Jeongmok Cho, Changsik John Pak, Hyunsuk Peter Suh, Jae Yong Jeon, Joon Pio Hong

    Published 2024-05-01
    “…The mammalian target of rapamycin (mTOR) inhibitors are used to prevent organ transplant rejection and are preferred over other immunosuppressants due to its low nephrotoxicity. …”
    Get full text
    Article
  13. 393

    Efectos pleiotrópicos de las estatinas: Características farmacológicas útiles en la prevención, tratamiento y regresión de la enfermedad cardiovascular Pleiotropic effect of statin... by Darío Echeverri, Lorena Buitrago, Félix R Montes

    Published 2005-09-01
    “…The potent hypolipemic and pleiotropic effects could explain the benefit in atherosclerosis, arterial hypertension, diabetes mellitus, aortic stenosis, psoriasis, multiple sclerosis and post-transplant rejection, among other pathologies. Nevertheless, the amount of experimental information in favour of these effects should stimulate the initiation of better studies in order to clarify in an accurate way its clinical significance.…”
    Get full text
    Article
  14. 394

    Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome? by Maryam Mozaffar, Shahrzad Shahidi, Marjan Mansourian, Shirinsadat Badri

    Published 2018-01-01
    “…Organ transplant recipients receive immunosuppressive regimens to prevent transplant rejection, which put them at increased risk for opportunistic infections like cytomegalovirus (CMV). …”
    Get full text
    Article
  15. 395

    Prospects of the Use of Cell Therapy to Induce Immune Tolerance by Zhenkun Wang, Xiaolong Liu, Xiaolong Liu, Fenglin Cao, Joseph A. Bellanti, Jin Zhou, Song Guo Zheng

    Published 2020-05-01
    “…Conditions in which abnormal or excessive immune responses exist, such as autoimmune diseases (ADs), graft-versus-host disease, transplant rejection, and hypersensitivity reactions, are serious hazards to human health and well-being. …”
    Get full text
    Article
  16. 396

    Abacavir-reactive memory T cells are present in drug naïve individuals. by Andrew Lucas, Michaela Lucas, Anette Strhyn, Niamh M Keane, Elizabeth McKinnon, Rebecca Pavlos, Ellen M Moran, Viola Meyer-Pannwitt, Silvana Gaudieri, Lloyd D'Orsogna, Spyros Kalams, David A Ostrov, Søren Buus, Bjoern Peters, Simon Mallal, Elizabeth Phillips

    Published 2015-01-01
    “…CONCLUSIONS:We propose that these pre-existing abacavir-reactive memory CD8+ T-cell responses must have been primed by earlier exposure to another foreign antigen and that these T cells cross-react with an abacavir-HLA-B*57:01-endogenous peptide ligand complex, in keeping with the model of heterologous immunity proposed in transplant rejection.…”
    Get full text
    Article
  17. 397

    Mapping stain distribution in pathology slides using whole slide imaging by Fang-Cheng Yeh, Qing Ye, T Kevin Hitchens, Yijen L Wu, Anil V Parwani, Chien Ho

    Published 2014-01-01
    “…It also provides a way to validate/correlate cellular MRI data used for tracking immune-cell infiltration in cardiac transplant rejection and cardiac ischemic injury.…”
    Get full text
    Article
  18. 398

    Opportunities for Engaging Patients in Kidney Research by Maryam N. Demian, Ngan N. Lam, Fabrice Mac-Way, Ruth Sapir-Pichhadze, Nicolas Fernandez

    Published 2017-04-01
    “…The 4 research programs span the spectrum of kidney disease and focus on enhancing bone health, increasing living donor kidney transplants, improving medication adherence, and preventing kidney transplant rejection. Sources of Information: The sources of information for this review include published studies on the topics of patient engagement and the 4 research programs of the new investigators. …”
    Get full text
    Article
  19. 399

    The Immunosuppressant Tacrolimus (FK506) Facing the 21st Century: Past Findings, Present Applications and Future Trends by Carlos Barreiro, Ana Ibañez, Sonia Garrido-Chamorro, José Luis Barredo

    Published 2024-12-01
    “…Some of these events are reviewed, paying special attention to immunosuppressant drugs, which are one of the most relevant milestones in the prevention of organ transplant rejection. The discovery, industrial exploitation, mechanisms of action and side effects of several drugs exhibiting immunosuppressive effects (e.g., corticosteroids, nitrogen mustards, mycophenolic acid, rapamycin) are deeply detailed. …”
    Get full text
    Article
  20. 400

    Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome by Marine Besnard, Céline Sérazin, Jason Ossart, Anne Moreau, Nadège Vimond, Léa Flippe, Hanna Sein, Grace A. Smith, Stefania Pittaluga, Elise M.N. Ferré, Claire Usal, Ignacio Anegon, Annamari Ranki, Michail S. Lionakis, Pärt Peterson, Carole Guillonneau

    Published 2022-04-01
    “…Targeted monoclonal antibody (mAb) therapies show great promise for the treatment of transplant rejection and autoimmune diseases by inducing more specific immunomodulatory effects than broadly immunosuppressive drugs routinely used. …”
    Get full text
    Article